These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19823052)

  • 21. Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations.
    Xie HG; Xu ZH; Ou-Yang DS; Shu Y; Yang DL; Wang JS; Yan XD; Huang SL; Wang W; Zhou HH
    Pharmacogenetics; 1997 Dec; 7(6):503-14. PubMed ID: 9429236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan.
    Huang CC; Chien WP; Wong RH; Cheng YW; Chen MC; Chou MC; Lee H
    Dis Colon Rectum; 2007 Jul; 50(7):981-9. PubMed ID: 17525862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
    Wikman H; Thiel S; Jäger B; Schmezer P; Spiegelhalder B; Edler L; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H; Risch A
    Pharmacogenetics; 2001 Mar; 11(2):157-68. PubMed ID: 11266080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between N-acetyltransferase 2 gene polymorphisms and pancreatic cancer.
    Ayaz L; Ercan B; Dirlik M; Atik U; Tamer L
    Cell Biochem Funct; 2008 Apr; 26(3):329-33. PubMed ID: 18027363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between N-acetyl transferase-2 gene polymorphism and risk of bronchial asthma.
    Tamer L; Calikoğlu M; Aras Ateş N; Yildirim H; Karakaş S; Atik U
    Tuberk Toraks; 2006; 54(2):137-43. PubMed ID: 16924569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.
    Kamel AM; Ebid GT; Moussa HS
    Tumour Biol; 2015 Aug; 36(8):6341-8. PubMed ID: 25804798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
    Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
    Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
    Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
    Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between genetic polymorphisms of glutathione S-transferase P1 and N-acetyltransferase 2 and susceptibility to squamous-cell carcinoma of the esophagus.
    Morita S; Yano M; Tsujinaka T; Ogawa A; Taniguchi M; Kaneko K; Shiozaki H; Doki Y; Inoue M; Monden M
    Int J Cancer; 1998 Oct; 79(5):517-20. PubMed ID: 9761122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.
    Varzim G; Monteiro E; Silva R; Pinheiro C; Lopes C
    ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):206-12. PubMed ID: 12037388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between polymorphism of N-acetyltransferase 2 and genetic susceptibility to laryngeal carcinoma].
    Lei D; Pan X; Guo C; Xu F; Zhang L; Liu D; Luan X
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):154-6. PubMed ID: 12015038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population.
    Al-Shaqha WM; Alkharfy KM; Al-Daghri NM; Mohammed AK
    Ann Saudi Med; 2015; 35(3):214-21. PubMed ID: 26409796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
    Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
    Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population.
    Liu HE; Hsiao PY; Lee CC; Lee JA; Chen HY
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):661-5. PubMed ID: 18349284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NAT2 fast acetylator genotypes are associated with an increased risk for lung cancer with wildtype epidermal growth factor receptors in Taiwan.
    Lee CN; Yu MC; Bai KJ; Chang JH; Fang CL; Hsu HL; Huang BS; Lu PC; Liu HE
    Lung Cancer; 2009 Apr; 64(1):9-12. PubMed ID: 18706736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
    Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
    Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
    Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
    Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE
    Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.